--2024/Q4-- / 7.722B--
Oct 30, 20242024/Q38.012B / 8.007B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--
--2023/Q48.052B / 7.621B--
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 36.760
- -0.250-0.68%
Close Oct 31 16:00 ET
- 36.775
- +0.015+0.04%
Post 16:10 ET
76.19BMarket Cap23.37P/E (TTM)
37.010High36.070Low11.32MVolume36.270Open37.010Pre Close414.01MTurnover0.56%Turnover Ratio11.83P/E (Static)2.07BShares45.36052wk High4.20P/B73.80BFloat Cap32.62452wk Low1.60Dividend TTM2.01BShs Float45.360Historical High4.35%Div YieldTTM2.54%Amplitude6.446Historical Low36.580Avg Price1Lot Size
GlaxoSmithKline Key Stats
GlaxoSmithKline Q3 2024 Earnings Date
Currency：GBPOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 8.01B | 8.01B | +5.14M |
| Beat Est. | -1.72% | -1.66% | +0.06% |
| EPS | 0.12 | -0.03 | -0.14 |
| Miss Est. | -84.82% | -103.93% | -124.05% |
Analyst Rating
Oct 31, 2024
GlaxoSmithKline Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
GlaxoSmithKline Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
